Article: Nicotinamide Riboside Lowers Cardiometabolic Risk Factors and Cardiac Oxidative Stress: Preclinical Findings

PrevNext
Cardiovascular Disease Cardiovascular Health Preclinical

Nicotinamide Riboside Lowers Cardiometabolic Risk Factors and Cardiac Oxidative Stress: Preclinical Findings

Synopsis

Nicotinamide riboside (NR), known to boost NAD levels, was tested alone and combined with calorie restriction (CR) to evaluate effects on obesity and heart health in rats fed a high-calorie, processed diet. NR treatment reduced body weight gain, decreased visceral and subcutaneous fat, improved insulin resistance, lowered triglyceride/HDL ratios, and reduced heart size. In the heart, NR enhanced antioxidant enzymes like glutathione peroxidase and catalase (especially with CR) and lowered the harmful NADPH oxidase enzyme in both obese and lean rats. However, NR treatment also caused some adverse effects like high blood sugar, triglycerides, and oxidative damage in the heart depending on the metabolic state. This study shows NR has anti-obesity and cardiometabolic benefits and modulates heart oxidative stress, highlighting its potential as a natural therapy in obesity-related heart disease.

Journal

Life Sciences

Share

Read more

Metabolic Health

Coronavirus Disrupts NAD+ Metabolism, While Nicotinamide Riboside Decreases Viral Replication: Preclinical Findings

Synopsis Certain enzymes called PARPs, which use NAD+ to modify proteins, play a role in the body’s defense against coronaviruses. Researchers found that SARS-CoV-2 infection increases the levels ...

Read more
Healthy Aging & Longevity

CD38 Deletion and Nicotinamide Riboside Supplementation Slow Axon Degeneration After Facial Nerve Injury: Preclinical Findings

Synopsis After facial nerve injury (axotomy), nerve function often does not fully recover due to axon degeneration, neuron death, and ongoing inflammation. CD38, an enzyme that breaks down NAD+, m...

Read more